At the beginning of this year, the Food and Drug Administration asked the makers of zolpidem (most commonly found in Ambien) to come up with new labels that clearly outline the perceived dangers of the drug. Now, the FDA has given its approval to new labels which stipulate both a lower dosage recommendation and a greater risk to females. The warnings also urge persons who take drugs like Ambien to take the proper precautions up to 24 hours after use. The medication has been shown to imperil alertness the next day, and thus activities like driving should be delayed until one can be sure the drug is out of their system.
Click here for more information.